These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22573121)
1. Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism. Calò LA; Davis PA; Pagnin E; Dal Maso L; Caielli P; Rossi GP J Hypertens; 2012 Jul; 30(7):1406-13. PubMed ID: 22573121 [TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754 [TBL] [Abstract][Full Text] [Related]
3. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension. Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802 [TBL] [Abstract][Full Text] [Related]
4. Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients. Calò LA; Davis PA J Hypertens; 2010 Oct; 28(10):2169-70; author reply 2171. PubMed ID: 20844372 [No Abstract] [Full Text] [Related]
5. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences. Calò LA; Maiolino G; Pagnin E; Vertolli U; Davis PA Eur J Clin Invest; 2014 Jun; 44(6):567-72. PubMed ID: 24739026 [TBL] [Abstract][Full Text] [Related]
6. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells? Tura O; Mills NL; Hadoke PW J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373 [No Abstract] [Full Text] [Related]
7. Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans. Maiolino G; Azzolini M; Rossi GP; Davis PA; Calò LA Free Radic Biol Med; 2015 Nov; 88(Pt A):51-8. PubMed ID: 25770663 [TBL] [Abstract][Full Text] [Related]
8. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways. Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243 [TBL] [Abstract][Full Text] [Related]
9. Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. Calò LA; Dal Maso L; Pagnin E; Ravarotto V; Facco M; Boscaro E; Maiolino G; Pessina AC; Rossi GP J Hypertens; 2014 Jan; 32(1):193-9. PubMed ID: 24309489 [TBL] [Abstract][Full Text] [Related]
10. Low circulating level of CD133+KDR+cells in patients with systemic sclerosis. Mok MY; Yiu KH; Wong CY; Qiuwaxi J; Lai WH; Wong WS; Tse HF; Lau CS Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S19-25. PubMed ID: 21050541 [TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. Zhou Z; Hu CP; Wang CJ; Li TT; Peng J; Li YJ Atherosclerosis; 2010 Nov; 213(1):92-101. PubMed ID: 20832068 [TBL] [Abstract][Full Text] [Related]
12. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma. Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979 [TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557 [TBL] [Abstract][Full Text] [Related]
16. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. Zhou Z; Peng J; Wang CJ; Li D; Li TT; Hu CP; Chen XP; Li YJ J Hypertens; 2010 May; 28(5):931-9. PubMed ID: 20375903 [TBL] [Abstract][Full Text] [Related]
17. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes. Calò LA; Davis PA Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397 [No Abstract] [Full Text] [Related]